Exclusive Virtual Meeting for ANPA with Previous AANP President as Presenter

It is with great pleasure we extend the following invitation

  A Closer Look at Obesity: Recognizing Obesity as a Heterogeneous and Chronic Disease 

          Presenter: ANGELA GOLDEN, NP, FAANP (AANP Past-President, 2012-2014)
          Tuesday, September 15, 2020 07:30 PM - 08:30 PM CDT 
          Novo Nordisk Webcast Interface Program - A Closer Look at Obesity: Recognizing Obesity as a Heterogeneous and Chronic Disease
          Host:  LINDSAY BEAN    

          Please click on the link below to register:
https://ahmdirect.adobeconnect.com/nn16074e/event/registration.html   

          Space is limited. Please RSVP at least 3 days prior to the event to confirm your reservation. 

          For more information about this program, please contact:    LINDSAY BEAN 
 +1 615-295-0921 liyb@novonordisk.com

Please note: This is a promotional presentation; it will not be certified for continuing medical education credit. 

Novo Nordisk is subject to federal and state laws that require the disclosure of items of value, such as meals, provided to certain health care professionals. By participating in this activity, the value of the meal will be reported as required, and that information may be publicly available. If you prefer to attend the program and not accept a meal,
there is a box to check at the event sign-in, indicating that you did not accept a meal. 

Due to certain state laws and regulations, if you: 1) are a health care provider in Minnesota, Vermont or New Jersey, or 2) are a member of a Medical Advisory Committee in the District of Columbia, or are a member of the Green Mountain Care Board in Vermont, please do not partake in any food and/or beverages available at this program. 

In accordance with the PhRMA Code on Interactions with Healthcare Professionals, attendance at this program is limited to health care professionals. Accordingly, attendance by guests or spouses is not appropriate and cannot be accommodated. 

We appreciate your understanding and apologize for any inconvenience this may cause. Please contact NNI Ethics & Compliance with any questions at 609-937-3816 or NNIComplianceAssistance@​novonordisk.com. 

          Replies to this message will not be received by your sales professional. Replies will be delivered to a Novo Nordisk mailbox for adverse event reporting and monitoring only. 

          Novo Nordisk is a registered trademark of Novo Nordisk A/S. 
          (c) 2020 Novo Nordisk   All rights reserved.